HPM Partners LLC Purchases Shares of 7,423 Masimo Corporation (MASI)

HPM Partners LLC purchased a new position in Masimo Corporation (NASDAQ:MASI) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 7,423 shares of the medical equipment provider’s stock, valued at approximately $979,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Fortaleza Asset Management Inc. bought a new position in Masimo Corporation in the 2nd quarter valued at approximately $106,000. Neuburgh Advisers LLC lifted its position in Masimo Corporation by 6.4% in the 1st quarter. Neuburgh Advisers LLC now owns 1,328 shares of the medical equipment provider’s stock valued at $124,000 after acquiring an additional 80 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Masimo Corporation by 32.2% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,782 shares of the medical equipment provider’s stock valued at $166,000 after acquiring an additional 434 shares in the last quarter. Glen Harbor Capital Management LLC lifted its position in Masimo Corporation by 6.4% in the 1st quarter. Glen Harbor Capital Management LLC now owns 1,826 shares of the medical equipment provider’s stock valued at $170,000 after acquiring an additional 110 shares in the last quarter. Finally, Dubuque Bank & Trust Co. lifted its position in Masimo Corporation by 3.4% in the 2nd quarter. Dubuque Bank & Trust Co. now owns 1,869 shares of the medical equipment provider’s stock valued at $170,000 after acquiring an additional 61 shares in the last quarter. 83.26% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This piece was first reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States and international copyright and trademark law. The original version of this piece can be viewed at https://sportsperspectives.com/2017/09/10/hpm-partners-llc-purchases-shares-of-7423-masimo-corporation-masi.html.

Masimo Corporation (NASDAQ MASI) opened at 86.14 on Friday. The company has a market capitalization of $4.47 billion, a PE ratio of 14.12 and a beta of 0.84. The stock’s 50 day moving average price is $87.92 and its 200 day moving average price is $91.12. Masimo Corporation has a 12-month low of $53.78 and a 12-month high of $104.71.

Masimo Corporation (NASDAQ:MASI) last posted its quarterly earnings data on Wednesday, August 2nd. The medical equipment provider reported $0.83 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.71 by $0.12. Masimo Corporation had a net margin of 45.90% and a return on equity of 23.45%. The business had revenue of $192.90 million during the quarter, compared to the consensus estimate of $189.03 million. During the same period in the previous year, the firm posted $0.57 earnings per share. The business’s revenue for the quarter was up 11.8% compared to the same quarter last year. On average, equities analysts anticipate that Masimo Corporation will post $2.80 EPS for the current fiscal year.

Several equities analysts recently issued reports on MASI shares. Stifel Nicolaus reaffirmed a “buy” rating and issued a $108.00 price objective (up from $105.00) on shares of Masimo Corporation in a research report on Thursday, August 3rd. Zacks Investment Research raised Masimo Corporation from a “sell” rating to a “hold” rating in a research report on Tuesday, July 11th. BidaskClub cut Masimo Corporation from a “buy” rating to a “hold” rating in a research report on Wednesday, July 5th. BTIG Research raised Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research report on Monday, August 14th. Finally, Roth Capital upped their price objective on Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a research report on Wednesday, July 19th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and four have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $95.00.

In related news, Director Sanford Fitch sold 14,000 shares of the business’s stock in a transaction on Thursday, June 29th. The shares were sold at an average price of $92.06, for a total transaction of $1,288,840.00. Following the completion of the transaction, the director now directly owns 90,249 shares in the company, valued at $8,308,322.94. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Anand Sampath sold 40,000 shares of the business’s stock in a transaction on Tuesday, July 11th. The shares were sold at an average price of $92.00, for a total transaction of $3,680,000.00. Following the transaction, the chief operating officer now owns 20,000 shares of the company’s stock, valued at $1,840,000. The disclosure for this sale can be found here. Insiders have sold 126,000 shares of company stock valued at $11,732,930 over the last quarter. Insiders own 16.60% of the company’s stock.

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply